Paul Himes' journey from a Terre Haute campus to a leading role in pharmaceutical safety highlights the impact of local education on global health. As Rose-Hulman Institute of Technology reported, Himes, a 2012 alumnus of chemistry and chemical engineering, developed an interest during his summers in a Rose-Hulman chemistry lab that ultimately led to his career focusing on the safety of drugs used for conditions such as diabetes, organ transplants, and lupus. He currently serves as a principal scientist for Sanofi, based in Framingham, Massachusetts, where he oversees the rigorous testing of treatments designed for complex, chronic, or rare diseases.
Himes’ path towards drug safety began during his third year at Rose-Hulman, when he first expressed an interest in the pharmaceutical industry. This interest was solidified when he began working in the laboratory of Professor Ross Weatherman, PhD. Professor Weatherman, who leads the Rose-Hulman Department of Chemistry & Biochemistry, engages students in research centered on developing treatments for breast cancer. This hands-on experience was transformative for Himes, who told Rose-Hulman Institute of Technology that he felt he was "actually making medicine." He emphasized understanding how these real-world drugs were created in a laboratory setting and how their composition could be altered through different chemical processes.
Inspired by this practical exposure, Himes decided to pursue chemistry as a second major, complementing his existing chemical engineering studies. He found that combining these rigorous scientific programs was a smooth process, attributing this ease to the focused curriculum and individualized support provided by Rose-Hulman. Himes noted that his decision to attend Rose-Hulman was partly based on the expectation of receiving more personalized attention, a belief he found to be true. He appreciated the opportunity to engage with professors in a capacity he believed would not have been possible at a larger university campus, fostering a unique learning environment.
Himes specifically credits the collaborative experiences he had with both faculty and fellow students at Rose-Hulman for shaping his career trajectory. He pointed to the institute’s emphasis on examining various methods of problem-solving, both in the classroom and within the lab, as a crucial foundation. He reflected on the intellectual environment of the campus, stating that Rose-Hulman "nurtures that curiosity." This institutional encouragement of inquisitive minds profoundly influenced his professional philosophy.
This ingrained sense of curiosity and critical inquiry continues to guide Himes in his current role. He explained that if he identifies an issue or something that appears incorrect, he is driven to understand the underlying reasons. For Himes, the explanation "it’s always been this way" is insufficient. His commitment to thorough investigation, honed during his academic years in Terre Haute, now underpins his responsibilities at Sanofi. Before joining Sanofi, Himes furthered his education, earning a doctoral degree in pharmaceutical sciences from the University of North Carolina. His career underscores the foundational role that early research opportunities and dedicated mentorship at local institutions like Rose-Hulman play in advancing vital scientific fields and contributing to public health on a broader scale.
